Biogen(BIIB) - 2024 Q3 - Quarterly Results

Press Release Cambridge, Mass. – October 30, 2024 Biogen reports third quarter 2024 results and raises full year 2024 financial guidance Third quarter 2024 revenue $2.5 billion; GAAP diluted EPS $2.66; Non-GAAP diluted EPS $4.08 Continued progress executing across the commercial portfolio • Product launches in Alzheimer's disease, rare disease, and depression each delivered sequential revenue growth; Total revenue from product launches in the third quarter continued to offset year-over-year decline in multi ...